Last I looked NWBO isn’t running any combo trials and pediatric stalled out too. But even if your IFR angle is true which I doubt, you can say goodbye to any ROI for shareholders.
This company is circling the drain. They can't get their product approved because the trial results were scientifically invalid. They have no choice except go back to the drawing board, or change their business model altogether. Why do you think it has been two years since they submitted the trial results and they haven't been approved? Do you think that means everything is going great? You need to wake up to reality. DCVax-L is dead in the water.